The intracellular signalosome of PD-L1 in cancer cells
David Escors(Navarrabiomed), Grazyna Kochan(Navarrabiomed)
Cited by 287
Related Papers
Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen‐specific regulatory T cells, and suppresses experimental inflammatory arthritis
|Arthritis & Rheumatism|2010|66
Highly differentiated CD4 T cells Unequivocally Identify Primary Resistance and Risk of Hyperprogression to PD-L1/PD-1 Immune Checkpoint Blockade in Lung Cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2018|26
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets
|Journal of Personalized Medicine|2021|8
Functional systemic CD4 immunity is a differential factor for clinical responses to PD-L1/PD-1 blockade therapy in lung cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2018|3